Masashi Nishikubo

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Bone marrow transplantation

British journal of haematology

Blood advances

Antibiotics (Basel, Switzerland)

Kobe University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Kobe University Apr 01 2009 - Mar 31 2015

Japan

PHD

Publications

Masashi Nishikubo, Hidemasa Matsuo, Sho Manabe, Kazuma Ota, Junko Ishii, Nobuhiro Hiramoto, Shigeo Hara, Tadakazu Kondo, Takayuki Ishikawa
Donor-derived CD8-predominant T cells in human graft-versus-host disease of the brain after allogeneic transplantation. British journal of haematology (2024)
Yosuke Nakaya, Hirohisa Nakamae, Masashi Nishikubo, Eisei Kondo, Takahiro Fukuda, Nobuhiro Hiramoto, Yasuo Mori, Koji Nagafuji, Tetsuya Eto, Yasushi Onishi, Naoyuki Uchida, Jun Ishikawa, Ken-Ichi Matsuoka, Shunsuke Yui, Ken Takase, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako
Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone marrow transplantation (2024)
Masashi Nishikubo, Hidemasa Matsuo, Sho Manabe, Kazuma Ota, Junko Ishii, Nobuhiro Hiramoto, Shigeo Hara, Tadakazu Kondo, Takayuki Ishikawa
Donor-derived CD8-predominant T cells in human graft-versus-host disease of the brain after allogeneic transplantation. British journal of haematology 204 (6) (2024)
Yosuke Okada, Yoshiaki Usui, Hiromi Hayashi, Masashi Nishikubo, Tomomi Toubai, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Satoshi Takahashi, Kazuteru Ohashi, Yasufumi Uehara, Yumiko Maruyama, Kazuya Ishiwata, Toshiro Kawakita, Masashi Sawa, Tetsuya Eto, Fumihiko Ishimaru, Koji Kato, Takahiro Fukuda, Yoshiko Atsuta, Junya Kanda, Kimikazu Yakushijin, Hideaki Nakasone
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score. Blood advances 8 (6) (2024)
Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, Hirohito Yamazaki, Takehiko Mori, Naoyuki Uchida, Kazuteru Ohashi, Jun Kato, Masashi Nishikubo, Shinichi Kako, Tetsuya Nishida, Shuichi Ota, Makoto Onizuka, Tetsuya Eto, Koichi Onodera, Kazuhiro Ikegame, Ken-Ichi Matsuoka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Yasushi Onishi
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 59 (5) (2024)
Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, Hirohito Yamazaki, Takehiko Mori, Naoyuki Uchida, Kazuteru Ohashi, Jun Kato, Masashi Nishikubo, Shinichi Kako, Tetsuya Nishida, Shuichi Ota, Makoto Onizuka, Tetsuya Eto, Koichi Onodera, Kazuhiro Ikegame, Ken-Ichi Matsuoka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Yasushi Onishi
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 59 (5) (2024)
Yosuke Okada, Yoshiaki Usui, Hiromi Hayashi, Masashi Nishikubo, Tomomi Toubai, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Satoshi Takahashi, Kazuteru Ohashi, Yasufumi Uehara, Yumiko Maruyama, Kazuya Ishiwata, Toshiro Kawakita, Masashi Sawa, Tetsuya Eto, Fumihiko Ishimaru, Koji Kato, Takahiro Fukuda, Yoshiko Atsuta, Junya Kanda, Kimikazu Yakushijin, Hideaki Nakasone
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score. Blood advances 8 (6) (2024)
Yosuke Nakaya, Hirohisa Nakamae, Masashi Nishikubo, Eisei Kondo, Takahiro Fukuda, Nobuhiro Hiramoto, Yasuo Mori, Koji Nagafuji, Tetsuya Eto, Yasushi Onishi, Naoyuki Uchida, Jun Ishikawa, Ken-Ichi Matsuoka, Shunsuke Yui, Ken Takase, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako
Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone marrow transplantation 59 (5) (2024)
Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto, Hirohito Yamazaki, Takehiko Mori, Naoyuki Uchida, Kazuteru Ohashi, Jun Kato, Masashi Nishikubo, Shinichi Kako, Tetsuya Nishida, Shuichi Ota, Makoto Onizuka, Tetsuya Eto, Koichi Onodera, Kazuhiro Ikegame, Ken-Ichi Matsuoka, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Yasushi Onishi
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2024)
Yosuke Nakaya, Hirohisa Nakamae, Masashi Nishikubo, Eisei Kondo, Takahiro Fukuda, Nobuhiro Hiramoto, Yasuo Mori, Koji Nagafuji, Tetsuya Eto, Yasushi Onishi, Naoyuki Uchida, Jun Ishikawa, Ken-Ichi Matsuoka, Shunsuke Yui, Ken Takase, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shinichi Kako
Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone marrow transplantation 59 (5) (2024)
Yosuke Okada, Yoshiaki Usui, Hiromi Hayashi, Masashi Nishikubo, Tomomi Toubai, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Satoshi Takahashi, Kazuteru Ohashi, Yasufumi Uehara, Yumiko Maruyama, Kazuya Ishiwata, Toshiro Kawakita, Masashi Sawa, Tetsuya Eto, Fumihiko Ishimaru, Koji Kato, Takahiro Fukuda, Yoshiko Atsuta, Junya Kanda, Kimikazu Yakushijin, Hideaki Nakasone
Development of an umbilical cord blood transplantation-specific non-relapse mortality risk assessment score. Blood advances (2024)
Satoshi Mitsuyuki, Masashi Nishikubo, Yoshimitsu Shimomura, Yukie Ohyama, Hayato Maruoka, Seiko Nasu, Tomoyo Kubo, Yuta Suzuki, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Ryusuke Yamamoto, Yuya Nagai, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Kohei Hasegawa, Hirokazu Kuroda, Toshikazu Hasuike, Asako Doi, Tadakazu Kondo, Takayuki Ishikawa
Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancy. European journal of haematology (2023)
Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Kenji Sakizono, Yuya Nagai, Nobuhiro Hiramoto, Noboru Yonetani, Tadakazu Kondo, Chisato Miyakoshi, Asako Doi, Takayuki Ishikawa
Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies. British journal of haematology (2023)
Masashi Nishikubo, Nobuhiro Hiramoto, Daisuke Yamashita, Hiroharu Imoto, Yoshitaka Sato, Yusuke Okuno, Hironori Haga, Yasuhito Nannya, Seishi Ogawa, Hiroshi Kimura, Takayuki Ishikawa
Elderly-onset systemic Epstein-Barr virus-positive T-cell lymphoma of childhood. Pathology international 72 (7) (2022)
Masashi Nishikubo, Yoshimitsu Shimomura, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Hiroharu Imoto, Ryusuke Yamamoto, Yuya Nagai, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Akiko Matsushita, Chisato Miyakoshi, Asako Doi, Takayuki Ishikawa
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: An observational study. British journal of haematology 197 (6) (2022)
Masashi Nishikubo, Yoshimitsu Shimomura, Nobuhiro Hiramoto, Naohiko Sawamura, Takako Yamaguchi, Shigeo Hara, Takayuki Ishikawa
Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report. BMC nephrology 22 (1) (2021)
Masashi Nishikubo, Maki Kanamori, Hiroaki Nishioka
Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid. Antibiotics (Basel, Switzerland) 8 (2) (2019)

Masashi Nishikubo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masashi Nishikubo